Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Cirrhosis × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 28 Neoplasms 13 Colonic Neoplasms 12 Breast Neoplasms 12 Prostatic Neoplasms 9 Polycythemia Vera 9 Venous Thromboembolism 8 Multiple Myeloma 8 Recurrence 6 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Thrombocythemia, Essential 4 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Esophageal Neoplasms 4 Cardiovascular Diseases 4 Barrett Esophagus 4 Stomach Neoplasms 3 Precancerous Conditions 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Tobacco Use Disorder 2 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2

Interventions

Ultrasonography 3 Tomography, X-Ray Computed 2 Colonoscopy 2 Blood Specimen Collection 2 tremelimumab 1 peginterferon alfa-2a 1 lenvatinib 1 hepatitis C immune globulin, human 1 fluoromisonidazole 1 epigallocatechin gallate 1 durvalumab 1 Weights and Measures 1 Vitamin B 6 1 Urination 1 Tomography 1 Tidal Volume 1 Tenofovir 1 Surgical Procedures, Operative 1 Standard of Care 1 Shadowing Technique, Histology 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiomics 1 Propranolol 1 Probiotics 1 Preoperative Exercise 1 Positron-Emission Tomography 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Population Groups 1 Plasmapheresis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡